South China Morning Post · Namita Joshi

India’s weight-loss price war begins as semaglutide patent expires

· By Vasudevan Sridharan
Story summary

Generic slimming drugs are expected to flood a market where one in four adults are currently either overweight or obese

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.